Abstract:Abstract Background Chemoresistance is a major obstacle that limits the benefits of 5-Fluorouracil (5-Fu)-based chemotherapy for colon cancer patients. Autophagy is an important cellular mechanism underlying chemoresistance. Recent research advances have given new insights into the use of natural bioactive compounds to overcome chemoresistance in colon cancer chemotherapy. As one of the multitargeted and safer phytomedicines, curcumin has been reported to work as cancer-specific chemosensitizer, presumably via induction of autophagic signaling pathways. The precise therapeutic effect of curcumin on autophagy in determining tumorous cells’ fate, however, remains unclear. This study was conducted to investigate the differential modulations of the treatments either with 5-Fu alone or 5-Fu combined with curcumin on cellular autophagic responses and viabilities in the human colon cancer cells HCT116 and HT29, and explore molecular signaling transductions underlying the curcumin-mediated autophagic changes and potentiation of 5-Fu’s cytotoxicity in vitro and in vivo. Methods Cell proliferation assay and morphology observation were used to identify the cytotoxicity of different combinations of curcumin and 5-Fu in HCT116 and HT29 cells. Cell immunofluorescence assay, Flow cytometry and Western blot were employed to detect changes of autophagy and the autophagy-related signaling pathways in the colon cancer cells and/or xenograft mice. Results Curcumin could significantly augment the cytotoxicity of 5-Fu to the tumorous cells, and the pre-treatment with curcumin followed by 5-Fu (pre-Cur) proved to be the most effective one compared to other two combinations. The chemosensitizing role of curcumin might attribute to the autophagy turnover from being activated in 5-Fu mono-treatment to being inhibited in the pre-Cur treatment as indicated by the changes in expression of beclin-1, p62 and LC3II/LC3I and the intensity of Cyto-ID Green staining. The autophagic alterations appeared to be contributed by down-regulation of not only the phospho-Akt and phospho-mTOR expressions but the phospho-AMPK and phospho-ULK1 levels as well. The cellular activation of AMPK by addition of A-769662 to the pre-Cur combination resulted in reversed changes in expressions of the autophagy protein markers and apoptotic status compared to those of the pre-Cur combination treatment. The findings were validated in the xenograft mice, in which the tumor growth was significantly suppressed in the mice with 25-day combination treatment, and meanwhile expressions of the autophagy markers, P-AMPK and P-ULK1 were all reversely altered in line with those observed in HCT116 cells. Conclusion Pre-treatment with curcumin followed by 5-Fu may mediate autophagy turnover both in vitro and in vivo via AMPK/ULK1-dependent autophagy inhibition and AKT modulation, which may account for the increased susceptibility of the colon cancer cells/xenograft to the cytotoxicity of 5-Fu.

Reverse Effect of Curcumin on CDDP-induced Drug-Resistance Via Keap1/p62-Nrf2 Signaling in A549/CDDP Cell.

Curcumin Prevents Induced Drug Resistance: A Novel Function?

Nrf2 is a Key Factor in the Reversal Effect of Curcumin on Multidrug Resistance in the HCT‑8/5‑Fu Human Colorectal Cancer Cell Line

In Vitro Study of the Effect of Cyclosporine A, Tetrandrine and Their Combination on the Reversion of Multidrug Resistance in Leukemia Cell Line.

Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level

Curcumin Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells Through a Reactive Oxygen Species-Dependent Mitochondrial Signaling Pathway.

[Empirical Study of Reverse Effect on Mediated Multidrug Resistance of U-2OS/ADM Cells with Curcumin in Vitro].

[Reversing Effects of Curcumin on Multi-Drug Resistance of Bel7402/5-fu Cell Line].

Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.

Curcumol Enhances the Sensitivity of Gastric Cancer to Cisplatin Resistance by Inducing Ferroptosis Through the P62/KEAP1/NRF2 Pathway

The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway

Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways

Effects of curcumin on HepG2 cell proliferation and expression of Keap1 and Nrf-2

Effect of Curcumin on Lapatinib Sensitivity and Lapatinib Resistance Associated Emt and Stem-Like Phenotype in Her2 Positive Breast Cancer.

Curcumin Reverses Oxaliplatin Resistance in Human Colorectal Cancer Via Regulation of TGF-β/Smad2/3 Signaling Pathway

Curcumin Reverses Doxorubicin Resistance Via Inhibition the Efflux Function of ABCB4 in Doxorubicin‑resistant Breast Cancer Cells.

RETRACTED ARTICLE: Curcumin Synergizes with 5-Fluorouracil by Impairing AMPK/ULK1-dependent Autophagy, AKT Activity and Enhancing Apoptosis in Colon Cancer Cells with Tumor Growth Inhibition in Xenograft Mice

The Short-Time Treatment with Curcumin Sufficiently Decreases Cell Viability, Induces Apoptosis and Copper Enhances These Effects in Multidrug-Resistant K562/A02 Cells

Effect of curcumin on proliferation of human lung adenocarcinoma cell line A549/DDP

Curcumin Induces Cell Death And Restores Tamoxifen Sensitivity In The Antiestrogen-Resistant Breast Cancer Cell Lines Mcf-7/Lcc2 And Mcf-7/Lcc9

Effect of curcumin on P-glycoprotein activity and expression of MDR1 gene mRNA in Caco-2 cells